FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311864915> ?p ?o ?g. }

• W4311864915 abstract "Introduction Membrane-bound angiotensin-converting enzyme-2 (ACE2) in epithelial cells is the main receptor for SARS-CoV-2. The extracellular portion of ACE2 may be shedded to plasma in which process ADAM17 (a disintegrin and metalloproteinase 17) is important. Results on the relationship between circulating levels of the soluble form of ACE2 (sACE2) and disease severity are inconclusive. This study investigates if sACE2 concentration correlates with COVID-19 severity, and whether this is affected by sex. Materials and methods Soluble form of ACE2 was analyzed in three groups: 104 patients (23 women and 81 men) with severe COVID-19 admitted to an intensive care unit (ICU), patients with moderate COVID-19 who required hospital care ( n = 19, 4 women and 15 men), and age and sex matched healthy controls ( n = 20, 4 women and 16 men). Blood samples were collected at hospital admission between 18 March 2020, and 3 May 2021, and at follow-up between 27 October 2020, and 19 October 2021. Circulating sACE2 (μg/L) was measured in EDTA plasma with a sensitive enzyme-linked immunosorbent assay. Additionally, CRP, ferritin, and lymphocyte count were analyzed during hospital stay. Results In total, 23 patients (22%) died in the ICU. When comparing healthy controls [mean age 58.1 (SD 11.4) years] and patients with moderate COVID-19 [mean age 61.0 (SD 13.2) years] with patients in the ICU [mean age 63.6 (SD 11.6) years], we found that sACE2 concentration decreased (70% reduction) with disease severity in men ( p = 0.002) but increased 3.7-fold with severity in women ( p = 0.043), suggesting a sex-related difference in how COVID-19 severity is related to sACE2 concentration. Moreover, we identified a relationship between inflammatory biomarkers and sACE2 concentration during the intensive care treatment, such that higher CRP and higher ferritin concentration correlated with lower sACE2 concentration in men. Conclusion The decrease in sACE2 concentration, selectively in men, in severe COVID-19 is of pathophysiological interest since men are affected more severely by the disease compared to women. Additionally, the inflammatory biomarkers, CRP and ferritin, correlated inversely with sACE2 concentration, suggesting a role in severe disease. Our findings imply that sACE2 is a possible biomarker of disease severity in a sex-specific manner." @default.
• W4311864915 created "2023-01-01" @default.
• W4311864915 creator A5018810546 @default.
• W4311864915 creator A5020077464 @default.
• W4311864915 creator A5028249449 @default.
• W4311864915 creator A5033006932 @default.
• W4311864915 creator A5039302045 @default.
• W4311864915 creator A5043688599 @default.
• W4311864915 creator A5053373507 @default.
• W4311864915 creator A5058215897 @default.
• W4311864915 creator A5073058126 @default.
• W4311864915 date "2022-12-08" @default.
• W4311864915 modified "2023-10-17" @default.
• W4311864915 title "Sex difference in circulating soluble form of ACE2 protein in moderate and severe COVID-19 and healthy controls" @default.
• W4311864915 cites W1977943652 @default.
• W4311864915 cites W2167384912 @default.
• W4311864915 cites W2729700337 @default.
• W4311864915 cites W2736267104 @default.
• W4311864915 cites W3009912996 @default.
• W4311864915 cites W3011995143 @default.
• W4311864915 cites W3020909574 @default.
• W4311864915 cites W3025862068 @default.
• W4311864915 cites W3034858522 @default.
• W4311864915 cites W3039803533 @default.
• W4311864915 cites W3042292025 @default.
• W4311864915 cites W3044783198 @default.
• W4311864915 cites W3047003416 @default.
• W4311864915 cites W3081085074 @default.
• W4311864915 cites W3088385564 @default.
• W4311864915 cites W3091960655 @default.
• W4311864915 cites W3094625820 @default.
• W4311864915 cites W3094625923 @default.
• W4311864915 cites W3110993746 @default.
• W4311864915 cites W3123786390 @default.
• W4311864915 cites W3128439668 @default.
• W4311864915 cites W3130896424 @default.
• W4311864915 cites W3136488945 @default.
• W4311864915 cites W3161330645 @default.
• W4311864915 cites W3163147065 @default.
• W4311864915 cites W3164646585 @default.
• W4311864915 cites W3171453642 @default.
• W4311864915 cites W3176574630 @default.
• W4311864915 cites W3177420748 @default.
• W4311864915 cites W3216660903 @default.
• W4311864915 cites W4206790144 @default.
• W4311864915 cites W4225515534 @default.
• W4311864915 cites W4281889570 @default.
• W4311864915 doi "https://doi.org/10.3389/fmed.2022.1058120" @default.
• W4311864915 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36569121" @default.
• W4311864915 hasPublicationYear "2022" @default.
• W4311864915 type Work @default.
• W4311864915 citedByCount "0" @default.
• W4311864915 crossrefType "journal-article" @default.
• W4311864915 hasAuthorship W4311864915A5018810546 @default.
• W4311864915 hasAuthorship W4311864915A5020077464 @default.
• W4311864915 hasAuthorship W4311864915A5028249449 @default.
• W4311864915 hasAuthorship W4311864915A5033006932 @default.
• W4311864915 hasAuthorship W4311864915A5039302045 @default.
• W4311864915 hasAuthorship W4311864915A5043688599 @default.
• W4311864915 hasAuthorship W4311864915A5053373507 @default.
• W4311864915 hasAuthorship W4311864915A5058215897 @default.
• W4311864915 hasAuthorship W4311864915A5073058126 @default.
• W4311864915 hasBestOaLocation W43118649151 @default.
• W4311864915 hasConcept C126322002 @default.
• W4311864915 hasConcept C203014093 @default.
• W4311864915 hasConcept C2775946041 @default.
• W4311864915 hasConcept C2776376669 @default.
• W4311864915 hasConcept C2778319317 @default.
• W4311864915 hasConcept C2779134260 @default.
• W4311864915 hasConcept C3008058167 @default.
• W4311864915 hasConcept C524204448 @default.
• W4311864915 hasConcept C71924100 @default.
• W4311864915 hasConcept C90924648 @default.
• W4311864915 hasConceptScore W4311864915C126322002 @default.
• W4311864915 hasConceptScore W4311864915C203014093 @default.
• W4311864915 hasConceptScore W4311864915C2775946041 @default.
• W4311864915 hasConceptScore W4311864915C2776376669 @default.
• W4311864915 hasConceptScore W4311864915C2778319317 @default.
• W4311864915 hasConceptScore W4311864915C2779134260 @default.
• W4311864915 hasConceptScore W4311864915C3008058167 @default.
• W4311864915 hasConceptScore W4311864915C524204448 @default.
• W4311864915 hasConceptScore W4311864915C71924100 @default.
• W4311864915 hasConceptScore W4311864915C90924648 @default.
• W4311864915 hasLocation W43118649151 @default.
• W4311864915 hasLocation W43118649152 @default.
• W4311864915 hasLocation W43118649153 @default.
• W4311864915 hasLocation W43118649154 @default.
• W4311864915 hasOpenAccess W4311864915 @default.
• W4311864915 hasPrimaryLocation W43118649151 @default.
• W4311864915 hasRelatedWork W1990646739 @default.
• W4311864915 hasRelatedWork W2050321550 @default.
• W4311864915 hasRelatedWork W2362122205 @default.
• W4311864915 hasRelatedWork W2591366330 @default.
• W4311864915 hasRelatedWork W3132916626 @default.
• W4311864915 hasRelatedWork W4224919177 @default.
• W4311864915 hasRelatedWork W4225937913 @default.
• W4311864915 hasRelatedWork W4287529139 @default.
• W4311864915 hasRelatedWork W4311787753 @default.
• W4311864915 hasRelatedWork W4386339104 @default.
• W4311864915 hasVolume "9" @default.

• next